Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Variability of HIV-1 for Drug Resistance Assay Development.

Viruses - 11 Feb 2016

Clutter Dana S, Rojas Sánchez Patricia, Rhee Soo-Yon, Shafer Robert W

Abstract excerpt

A hybridization-based point-of-care (POC) assay for HIV-1 drug resistance would be useful in low- and middle-income countries (LMICs) where resistance testing is not routinely available. The major obstacle in developing such an assay is the extreme genetic variability of HIV-1. We analyzed 27,203 reverse transcriptase (RT) sequences from the Stanford HIV Drug Resistance Database originating from six LMIC regions....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Base Sequence
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to Molecular Sequence Data

Share to Mutation

Source

Open in PubMed Open full text

Identifiers

PMID: 26875985
DOI: 10.3390/v8020048
PMCID: PMC4776203

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Variability of HIV-1 for Drug Resistance Assay Development.PMID 26875985Read ↗

Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings.Semantic proximity Read ↗

HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing.Semantic proximity Read ↗

Near-point-of-care assay with a visual readout for detection of HIV-1 drug resistance mutations: A proof-of-concept study.Semantic proximity Read ↗

Long-Range HIV Genotyping Using Viral RNA and Proviral DNA for Analysis of HIV Drug Resistance and HIV Clustering.Semantic proximity Read ↗

HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies.Semantic proximity Read ↗

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation.Semantic proximity Read ↗

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID.Semantic proximity Read ↗

Low-Abundance Drug-Resistant HIV-1 Variants: Finding Significance in an Era of Abundant Diagnostic and Therapeutic OptionsSemantic proximity Read ↗

Whole-Genome Sequencing–Based Characterization of HIV-1 in a Tertiary-Care Hospital in Mexico: Drug-Resistance Mutations and Genetic DiversitySemantic proximity Read ↗

Bioinformatical assistance of selecting anti-HIV therapies: where do we stand?Semantic proximity Read ↗

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug ResistanceSemantic proximity Read ↗

Amplicon-Based Multiregion Genomic Characterization of HIV-1 in a Tertiary-Care Hospital in Mexico: Antiretroviral Resistance Mutations and Subtype Diversity.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.